Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Pediatrix Medical (MD) Receivables - Other (2017 - 2024)

Pediatrix Medical (MD) reported Receivables - Other of $28.5 million for Q4 2024, down 14.16% year-over-year from $33.2 million in Q1 2024, and down 14.16% on a QoQ basis from $33.2 million in Q4 2023.

Pediatrix Medical (MD) has 8 years of Receivables - Other data on file, last reported at $28.5 million in Q4 2024.

  • Quarterly Receivables - Other fell 14.16% year-over-year to $28.5 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $28.5 million (down 14.16% YoY) and the FY2024 annual result came in at $28.5 million, down 14.16% from the prior year.
  • Receivables - Other declined to $28.5 million in Q4 2024 per MD's latest filing, from $33.2 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $61.4 million in Q4 2020 and bottomed at $28.5 million in Q4 2024.
  • The 5-year median for Receivables - Other is $54.7 million (2022), against an average of $47.2 million.
  • The widest annual swing landed in 2020, when Receivables - Other soared 106.04%; it then plunged 39.31% in 2023.
  • Tracing MD's Receivables - Other over 5 years: stood at $61.4 million in 2020, then retreated by 5.37% to $58.1 million in 2021, then dropped by 5.85% to $54.7 million in 2022, then sank by 39.31% to $33.2 million in 2023, then declined by 14.16% to $28.5 million in 2024.
  • Per Business Quant, the three latest MD Receivables - Other figures stand at $28.5 million (Q4 2024), $33.2 million (Q4 2023), and $54.7 million (Q4 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 Pediatrix Medical 1.74 Bn 1.41 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 28.50 Mn
Dec 31, 2024 28.50 Mn
Dec 31, 2023 33.20 Mn
Dec 31, 2023 33.20 Mn
Dec 31, 2022 54.70 Mn
Dec 31, 2022 54.70 Mn
Dec 31, 2021 58.10 Mn
Dec 31, 2021 58.10 Mn
Dec 31, 2020 61.40 Mn
Dec 31, 2020 61.40 Mn
Dec 31, 2019 29.80 Mn
Dec 31, 2019 29.80 Mn
Dec 31, 2018 16.70 Mn
Dec 31, 2018 16.70 Mn
Dec 31, 2017 18.90 Mn
Dec 31, 2017 18.90 Mn